Today's Date
Efficacy And Safety Evaluation Of Allergen Immunotherapy Co-Administered With Omalizumab, An Anti-IgE Monoclonal Antibody
(
)
ITN Protocol #:
ITN019AD
Branded Name:
ClinicalTrials.Gov ID:
NCT00078195Treatment Protocol #:
Therapeutic Area:
Allergy & Asthma
Current Status:
Completed
Summary:
A series of allergy shots may reduce symptoms of seasonal ragweed allergies. This study will determine whether taking a drug called omalizumab (also known as Xolair) before getting the allergy shots is more effective than allergy shots alone or other treatments, such as prescription antihistamines.